2026. Integrating Artificial Intelligence, Regulatory Diversity Mandates, and Federated Learning Architectures to Advance Equity and Interpretability in Global Randomized Clinical Trials . EuroLexis Research Index of International Multidisciplinary Journal for Research & Development. 13, 2 (Feb. 2026), 1–5.